Oral phenylbutyrate vs placeboMuscle strength · children with SMA type II1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 70 participantsLow